These included genes involved in cancer progression (PDK4, GPX3, LMAN1, RP11-124N14.3 and PAK6), factors implicated in cytokine response (TNFRSF12A, UBE2J1 and MAP1B), as well as those important for cytoskeleton remodelling, decreased intercellular adhesion and cancer stem cell transformation (EZR and CD44). This evidence concerns the gene TNFRSF12A and cancer.